Literature DB >> 15967000

Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.

Rafael Ponikvar1, Jadranka Buturović-Ponikvar.   

Abstract

The objective was to review our experience with temporary, precurved, jugular catheters used for long-term vascular access in chronic hemodialysis patients. Thirty chronic hemodialysis patients, 14 men and 16 women, with an average age of 65.3 +/- 13.5 years (30-90 years), treated by dialysis for 1 month to 30 years (average +/- SD, 6.3 +/- 8.1 years), had single lumen, 'temporary' precurved non-tunneled jugular catheters placed into the right jugular vein as permanent vascular access, with 4% trisodium citrate as a locking solution and mupirocin at the exit site. Hemodialysis catheters were used for vascular access on average for 9.1 +/- 6.5 months, (1-22.7 months), and for a total of 271.7 months (8151 days). Average catheter functioning time was 3.1 +/- 1.9 months (0.5-10 months). The total number of side-effects was 55 (6.7/1000 catheter days), including 26 cases of thrombosis (3.2/1000 catheter days), 9 ruptures of the catheter (1.1/1000 catheter days), 15 catheter malfunctions (1.8/1000 catheter days), 2 exit site infections (0.2/1000 catheter days), 2 bacteremias (0.2/1000 catheter days), 1 avulsion of the catheter (0.1/1000 catheter days), and 2 catheters were removed because an AV fistula was successfully used. In 21 patients single-needle hemodialysis was performed, mean blood flow 251 +/- 16 mL/min (250-300), mean Kt/V 0.96 +/- 0.16 (0.72-1.27) and in 9 patients double-needle hemodialysis was performed (catheter and peripheral vein) with mean blood flow 252 +/- 14 mL/min (200-300), mean Kt/V 1.63 +/- 0.25 (1.21-1.96). 'Temporary' jugular single lumen non-tunneled hemodialysis catheters, with 4% citrate as locking solution and mupirocin ointment at the exit site provided good long-term vascular access with acceptable functioning time and low infection rate. The main reasons for catheter exchange or removal were malfunction and mechanical damage of the catheter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967000     DOI: 10.1111/j.1774-9987.2005.00265.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  7 in total

1.  Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Authors:  Trevor J Wilkieson; Alistair J Ingram; Mark A Crowther; Steven D Soroka; Ryuta Nagai; Kailash K Jindal; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  Microbiology of Non-Tunnelled Catheter-Related Infections.

Authors:  Shefali Gupta; Shrikara P Mallya; Ashok Bhat; Shrikala Baliga
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).

Authors:  Franklin Correa Barcellos; Bruno Pereira Nunes; Luciana Jorge Valle; Thiago Lopes; Bianca Orlando; Cintia Scherer; Marcia Nunes; Gabriela Araújo Duarte; Maristela Böhlke
Journal:  Infection       Date:  2016-08-29       Impact factor: 3.553

Review 4.  Vascular access in elderly patients with end-stage renal disease.

Authors:  Nikolaos Bessias; Kosmas I Paraskevas; Effie Tziviskou; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

5.  Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/min.

Authors:  Robert I Griffiths; Britt B Newsome; Geoffrey A Block; Robert J Herbert; Mark D Danese
Journal:  Int J Nephrol       Date:  2011-12-08

6.  Maturation of arteriovenous fistulas in patients with and without preexisting hemodialysis catheters.

Authors:  Yuthapong Wongmahisorn
Journal:  Ann Med Surg (Lond)       Date:  2019-10-11

7.  A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis.

Authors:  Wannasit Wathanavasin; Jeerath Phannajit; Manorom Poosoonthornsri; Songkiat Lewsuwan; Patchara Tanateerapong; Kamonrat Chongthanakorn; Kullaya Takkavatakarn; Pisut Katavetin; Khajohn Tiranathanagul; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  Can J Kidney Health Dis       Date:  2021-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.